$KLRS
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
Healthcare
Sector
Biotechnology
Industry
Andrew Oxtoby
CEO
14
Employees
$6.50
Current Price
$49.48M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $12,868.80 | 1,915 | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $12,868.80 | 1,915 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $12,868.80 | 1,915 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $12,868.80 | 1,915 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $12,868.80 | 1,915 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 20, 2026 | Hagen Brett R Chief Accounting Officer | Sale | 1,915 | $6.72 | $12,868.80 | View Details |
2 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
Estimated-$0.59
ActualN/A
Revenue
EstimatedN/A
ActualN/A
EPS
Estimated-$0.59
Actual-$0.44
Beat
Revenue
EstimatedN/A
ActualN/A
EPS
Estimated-$0.59
Actual-$0.53
Beat
Revenue
EstimatedN/A
ActualN/A
EPS
Estimated-$0.56
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: